化学信息学和预测毒性建模中的分子相似性:从定量阅读交叉 (q-RA) 到定量阅读交叉结构-活性关系 (q-RASAR) 使用机器学习
Arkaprava Banerjee1, Supratik Kar2, Kunal Roy1
1Department of Pharmaceutical Technology, Drug Theoretics and Cheminformatics (DTC) Laboratory, Jadavpur University, Kolkata, India.
Critical reviews in toxicology
|September 3, 2024
概括
本综述涵盖了分子相似性,重点关注跨读 (RA) 和跨读结构-活性关系 (RASAR). 这些方法有助于预测建模,并填补化学性质的数据缺口,包括毒性评估.
科学领域:
- 化学信息学 化学信息学
- 计算化学是一种计算化学.
- 毒理学 毒理学 毒理学
背景情况:
- 分子相似性对于化学中的预测建模至关重要.
- 诸如定量结构-活性关系 (QSAR) 和交叉读取 (RA) 等计算工具对于填补数据空白至关重要,特别是对于监管环境中的毒性终点.
- 该综述追踪了RA的演变,从早期的结构信息使用到纳入物理化学,ADME和生物相似性背景.
研究的目的:
- 提供化学信息学和预测建模中分子相似性的全面审查.
- 批判性地检查阅读交叉 (RA) 和阅读交叉结构-活动关系 (RASAR) 方法.
- 突出最近的进展和新型模型,将RA与QSAR集成在一起.
主要方法:
- 关于分子相似性概念和应用的文献综述.
- 专注于阅读交叉 (RA) 方法及其发展.
- 探索像ToxRead,GenRA和q-RASAR这样的集成模型.
主要成果:
- 分子相似性,特别是RA和RASAR,是用于预测建模的强大方法.
- RA有效地解决了各种化学性质的数据缺口,包括毒性.
- 最近,RA与QSAR的整合导致了复杂的预测模型.
结论:
- 阅读和RASAR是化学信息学中必要的工具,用于填补数据缺口和监管科学.
- 关节炎的演变,包括各种相似性背景,增强了其预测能力.
- 新的综合模型代表了计算毒理学和财产预测方面的重大进步.
更多相关视频
00:05In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
13.9K
09:01A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
7.2K
相关概念视频
Molecular Models
38.1K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.1K
Evolutionary Relationships through Genome Comparisons
5.7K
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
5.7K
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
